发明名称 |
BIOENHANCED FORMULATIONS COMPRISING EPROSARTAN IN ORAL SOLID DOSAGE FORM |
摘要 |
This invention relates to bioenhanced formulations comprising eprosartan or eprosartan mesylate in the amorphous form, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
|
申请公布号 |
CA2338256(C) |
申请公布日期 |
2008.09.23 |
申请号 |
CA19992338256 |
申请日期 |
1999.07.20 |
申请人 |
SMITHKLINE BEECHAM CORPORATION |
发明人 |
VENKATESH, GOPADI;GUDIPATI, MANGA R. |
分类号 |
A61K31/4178;A61K9/14;A61K9/16;A61K9/20;A61K9/26;A61K31/138;A61K31/341;A61K31/401;A61K31/415;A61K31/44;A61K31/4409;A61K31/4422;A61K31/54;A61K31/549;A61K31/635;A61K47/32;A61P9/04;A61P9/12;A61P13/12;A61P43/00 |
主分类号 |
A61K31/4178 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|